A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies
Clinical trial NCT06878365 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06878365
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-29
- Primary completion
- 2026-12-06
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.